|
|
||||||||
The Journal of Immunology, Vol 155, Issue 2 886-894, Copyright © 1995 by American Association of Immunologists
ARTICLES |
LA Sheffler, DA Wink, G Melillo and GW Cox
Macrophage Cell Biology Section, National Cancer Institute-Frederick Cancer Research and Development Center, National Institutes of Health, MD 21702, USA.
This study was performed to determine the effects of nitric oxide (NO) on the expression of inducible NO synthase (iNOS) in mouse macrophages. We used the NO donor diethylamine dinitric oxide (DEA/NO) and the mouse macrophage cell line ANA-1 in these experiments. ANA-1 macrophages did not express iNOS mRNA either constitutively or following exposure to 100 U/ml IFN-gamma alone, to 10 ng/ml LPS alone, or to 200 microM DEA/NO alone. Similarly, ANA-1 macrophages did not express detectable levels of iNOS mRNA following treatment with 100 U/ml IFN-gamma plus 200 microM DEA/NO. However, IFN-gamma (100 U/ml) plus LPS (10 ng/ml) induced high levels of iNOS mRNA in ANA-1 macrophages after 6 h. Low concentrations of DEA/NO (approximately 1 to 12 microM) caused up to a 2.5-fold augmentation of IFN-gamma plus LPS-induced iNOS mRNA expression. In contrast, 200 microM DEA/NO suppressed IFN-gamma plus LPS-induced iNOS mRNA expression (60% decrease). The effects of DEA/NO were gene-specific because DEA/NO did not affect the IFN-gamma plus LPS- induced expression of TNF-alpha mRNA. Moreover, the biphasic effects of DEA/NO were specifically due to released NO. Diethylamine and nitrite were unable to regulate IFN-gamma plus LPS-induced gene expression in ANA-1 macrophages. Time-response experiments suggested that the effects of NO were short-lived and occurred early during the induction of iNOS gene expression. The effects of NO were not limited to iNOS mRNA expression but were apparent at the level of iNOS protein expression and enzymatic activity. Overall, these results suggest that NO has immunoregulatory effects and may control the extent and duration of cytokine- and/or endotoxin-induced iNOS expression in macrophages.
This article has been cited by other articles:
![]() |
J. Delgado Alves, L. J. Mason, P. R. J. Ames, P. P. Chen, J. Rauch, J. S. Levine, R. Subang, and D. A. Isenberg Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model Rheumatology, October 1, 2005; 44(10): 1238 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. El-Gayar, H. Thuring-Nahler, J. Pfeilschifter, M. Rollinghoff, and C. Bogdan Translational Control of Inducible Nitric Oxide Synthase by IL-13 and Arginine Availability in Inflammatory Macrophages J. Immunol., November 1, 2003; 171(9): 4561 - 4568. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, D. El Kebir, and G. Blaise Inhaled nitric oxide in 2003: a review of its mechanisms of action: [L'inhalation de monoxyde d'azote en 2003 : une revue de ses mecanismes et de son action] Can J Anesth, October 1, 2003; 50(8): 839 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Park, H.-J. Na, Y.-G. Kwon, K.-S. Ha, S.-J. Lee, C.-K. Kim, K.-S. Lee, T. Yoneyama, K. Hatakeyama, P. K. M. Kim, et al. Nitric Oxide (NO) Pretreatment Increases Cytokine-induced NO Production in Cultured Rat Hepatocytes by Suppressing GTP Cyclohydrolase I Feedback Inhibitory Protein Level and Promoting Inducible NO Synthase Dimerization J. Biol. Chem., November 27, 2002; 277(49): 47073 - 47079. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Skidgel, X.-p. Gao, V. Brovkovych, A. Rahman, D. Jho, S. Predescu, T. J. Standiford, and A. B. Malik Nitric Oxide Stimulates Macrophage Inflammatory Protein-2 Expression in Sepsis J. Immunol., August 15, 2002; 169(4): 2093 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Reuter, H. Bolay, I. Jansen-Olesen, A. Chiarugi, M. S. del Rio, R. Letourneau, T. C. Theoharides, C. Waeber, and M. A. Moskowitz Delayed inflammation in rat meninges: implications for migraine pathophysiology Brain, December 1, 2001; 124(12): 2490 - 2502. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. NUNES, D. LEBREC, M. MAZMANIAN, F. CAPRON, J. HELLER, K. A. TAZI, E. ZERBIB, E. DULMET, R. MOREAU, A. T. DINH-XUAN, et al. Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic Rats Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 879 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Parmely, F. Wang, and D. Wright Gamma Interferon Prevents the Inhibitory Effects of Oxidative Stress on Host Responses to Escherichia coli Infection Infect. Immun., April 1, 2001; 69(4): 2621 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Connelly, M. Palacios-Callender, C. Ameixa, S. Moncada, and A. J. Hobbs Biphasic Regulation of NF-{{kappa}}B Activity Underlies the Pro- and Anti-Inflammatory Actions of Nitric Oxide J. Immunol., March 15, 2001; 166(6): 3873 - 3881. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Blond, H. Raoul, R. Le Grand, and D. Dormont Nitric Oxide Synthesis Enhances Human Immunodeficiency Virus Replication in Primary Human Macrophages J. Virol., October 1, 2000; 74(19): 8904 - 8912. [Abstract] [Full Text] |
||||
![]() |
H. E. MARSHALL, K. MERCHANT, and J. S. STAMLER Nitrosation and oxidation in the regulation of gene expression FASEB J, October 1, 2000; 14(13): 1889 - 1900. [Abstract] [Full Text] |
||||
![]() |
F. Wang, L. Y. Wang, D. Wright, and M. J. Parmely Redox Imbalance Differentially Inhibits Lipopolysaccharide-Induced Macrophage Activation in the Mouse Liver Infect. Immun., October 1, 1999; 67(10): 5409 - 5416. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, L. W. Velsor, J. M. Patel, E. M. Postlethwait, and E. R. Block Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-kappa B Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L787 - L793. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bobe, K. Benihoud, D. Grandjon, P. Opolon, L. L. Pritchard, and R. Huchet Nitric Oxide Mediation of Active Immunosuppression Associated With Graft-Versus-Host Reaction Blood, August 1, 1999; 94(3): 1028 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bellocq, E. Azoulay, S. Marullo, A. Flahault, B. Fouqueray, C. Philippe, J. Cadranel, and L. Baud Reactive Oxygen and Nitrogen Intermediates Increase Transforming Growth Factor-beta 1 Release from Human Epithelial Alveolar Cells through Two Different Mechanisms Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 128 - 136. [Abstract] [Full Text] |
||||
![]() |
Y. Vodovotz, L. Chesler, H. Chong, S.-J. Kim, J. T. Simpson, W. DeGraff, G. W. Cox, A. B. Roberts, D. A. Wink, and M. H. Barcellos-Hoff Regulation of Transforming Growth Factor {beta}1 by Nitric Oxide Cancer Res., May 1, 1999; 59(9): 2142 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Facchetti, W. Vermi, S. Fiorentini, M. Chilosi, A. Caruso, M. Duse, L. D. Notarangelo, and R. Badolato Expression of Inducible Nitric Oxide Synthase in Human Granulomas and Histiocytic Reactions Am. J. Pathol., January 1, 1999; 154(1): 145 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
HarryM. Lander, DavidP. Hajjar, BarbaraL. Hempstead, UroojA. Mirza, BrianT. Chait, S. Campbell, and LawrenceA. Quilliam A Molecular Redox Switch on p21ras. STRUCTURAL BASIS FOR THE NITRIC OXIDE-p21ras INTERACTION J. Biol. Chem., February 14, 1997; 272(7): 4323 - 4326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Hill, J. A. Corbett, G. Kwon, C. A. Marshall, and M. L. McDaniel Nitric Oxide Regulates Interleukin 1Bioactivity Released from Murine Macrophages J. Biol. Chem., September 13, 1996; 271(37): 22672 - 22678. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |